Carregant...
TP53 in bone and soft tissue sarcomas
Genomic and functional study of existing and emerging sarcoma targets, such as fusion proteins, chromosomal aberrations, reduced tumor suppressor activity, and oncogenic drivers, is broadening our understanding of sarcomagenesis. Among these mechanisms, the tumor suppressor p53 (TP53) plays signific...
Guardat en:
| Publicat a: | Pharmacol Ther |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6746598/ https://ncbi.nlm.nih.gov/pubmed/31276706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2019.06.010 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|